Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Pennsylvania
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in Pennsylvania
5 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 1
Up to age 39 · All sexes · Updated Sep 11, 2026 · NCT04972942Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 1
Ages 0 to 29 · All sexes · Updated Jul 7, 2026 · NCT06934382A Registry for People With T-cell Lymphoma
- University of Pennsylvania (Data Collection Only), Philadelphia
- Thomas Jefferson University Hospital (Data collection only), Philadelphia
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Two Step Haplo With Radiation Conditioning
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadephia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 30, 2025 · NCT05031897From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.